Merit Medical Systems Inc
Research Merit Medical Systems Inc (MMSI) on Bullrun: valuation model: 7.1% overvalued, market cap USD 5.44B, P/E 37.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMMSI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal7.1% overvalued
- Market capUSD 5.44B
- P/E37.5
- Financial periodQ2 2026
- RevenueUSD 418.84M
- Net incomeUSD 38.80M
- Free cash flowUSD 51.09M
- Gross margin51.4%
Valuation Snapshot
Bullrun's latest valuation model marks Merit Medical Systems Inc as 7.1% overvalued; latest market cap is USD 5.44B; P/E is 37.5.
Peer valuation comparison
Latest P/E is 37.55x versus a Healthcare sector median of 24.46x (53.5% above).
Latest P/E is 37.55x versus a United States median of 24.87x (51.0% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.52B | USD 128.49M | USD 215.66M | 48.7% | 2.13 | USD 446.40M | USD 734.04M | USD 1.58B |
| FY2024 | USD 1.36B | USD 120.36M | USD 185.66M | 47.4% | 2.03 | USD 376.72M | USD 729.55M | USD 1.38B |
| FY2023 | USD 1.26B | USD 94.41M | USD 110.86M | 46.4% | 1.62 | USD 587.04M | USD 823.01M | USD 1.20B |
| FY2022 | USD 1.15B | USD 74.52M | USD 69.26M | 45.1% | 1.29 | USD 58.41M | USD 198.01M | USD 1.14B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 5.44B | 37.5 | n/a | n/a |
| 2025 | 2025-12-31 | USD 5.24B | 41.4 | n/a | n/a |
| 2024 | 2024-12-31 | USD 5.68B | 47.6 | n/a | n/a |
| 2023 | 2023-12-29 | USD 4.39B | 44.2 | n/a | n/a |
| 2022 | 2022-12-30 | USD 4.02B | 66.0 | n/a | n/a |
| 2021 | 2021-12-31 | USD 3.52B | 74.2 | n/a | n/a |
About Merit Medical Systems Inc
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Merit Medical Systems Inc overvalued or undervalued?
Bullrun's valuation model currently marks Merit Medical Systems Inc as 7.1% overvalued.
What is Merit Medical Systems Inc's market cap?
Merit Medical Systems Inc's market capitalization is USD 5.44B.
What is Merit Medical Systems Inc's P/E ratio?
Merit Medical Systems Inc's price-to-earnings (P/E) ratio is 37.5.
What does Merit Medical Systems Inc do?
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy.